We thank Dana-Farber/Harvard Cancer Center in Boston, MA, for the use of the Rodent Histopathology Core, which provided tissue processing and histological service. We particularly thank pathologists Peter M. Howley for providing his expertise. We also thank the Dana-Farber Flow Cytometry Core ...
We thank the Dana-Farber/Harvard Cancer Center in Boston, MA, for the use of the Rodent Histopathology Core, which provided tissue processing and histopathological interpretation services. Dana-Farber/Harvard Cancer Center is supported in part by a NCI Cancer Center Support Grant # NIH 5 P30 CA...
Cancer Res., In press Google Scholar LeMaistre, C., Edwards, D., Dressier, L., Lathan, R., Mansel, R. and McGuire, W. (1986) Studies with monoclonal antibodies to breast tumors. In Ceriani, R. (ed.) Monoclonal Antibodies and Breast Cancer, pp. 80–5. (Boston: Martinus Nijhoff...
Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005. NIH publication 05-5282. 20. American Cancer Society (ACS). Cervix at a glance. ACS website.https://cancer...
"In my own opinion, the 'malariatherapy' endorsed by Dr. Heimlich has no scientific basis and should not be used on human subjects," said George J. Annas, a professor and director of the Center for Health Law, Ethics and Human Rights at the Boston University School of Public Health, Sc...
The International Center for the Control of Pain in Children and Adults http://www.nursing.uiowa.edu/sites/pedspain/resources/index.htm The Resource Center of the American Alliance of Cancer Pain Initiatives (AACPI) http://www.aacpi.org/patlinks.html Understanding Cancer Pain http://rex.nci...
Growing concern has arisen from the quasi-exponential increase in the numbers and quantities of man-made chemicals that presently are in current use, and their potential effects on human health, especially their delayed effects on degenerative diseases such as cancer. It is estimated that at least...
IMPORT LOW is a randomized, multi-center phase III trial testing partial breast radiotherapy (RT) using intensity modulated RT in women with early-stage br... A Kirby,C Griffin,L Finneran,... - 《International Journal of Radiation Oncology Biology Physics》 被引量: 0发表: 2023年 Once-Weekl...
Box and whiskers (minimum to maximum, median as center) are shown. Statistical significance was determined by one-way ANOVA in combination with Tukey’s test. IDHi, IDH inhibitor; p.o., per os. If not mentioned otherwise, all data are represented as mean ± s.e.m. Source data ...
Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA Rebecca C. Larson & Marcela V. Maus Immunology Program, Harvard Medical School, Boston, MA, USA Rebecca C. Larson & Marcela V. Maus Contributions M.V.M. and R.C.L. researched the data for the ...